1. Lloyd, Sarah E, Rossor, Martin, Fox, Nick, Mead, Simon, Collinge, John. 2009. HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q. In BMC medical genetics, 10, 90. doi:10.1186/1471-2350-10-90. https://pubmed.ncbi.nlm.nih.gov/19754925/
2. Sato, Masaaki. 2017. Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a. In Frontiers in cellular neuroscience, 11, 62. doi:10.3389/fncel.2017.00062. https://pubmed.ncbi.nlm.nih.gov/28326016/
3. Lv, Dong, Xiang, Ying, Song, Tao, Huili, Youlong, Shen, Taimin. 2024. HECTD2 as a target for veratric acid in the regulation of ferroptosis in renal cell carcinoma. In Amino acids, 56, 57. doi:10.1007/s00726-024-03419-0. https://pubmed.ncbi.nlm.nih.gov/39343853/
4. Lloyd, Sarah E, Maytham, Emma G, Pota, Hirva, Mead, Simon, Collinge, John. 2009. HECTD2 is associated with susceptibility to mouse and human prion disease. In PLoS genetics, 5, e1000383. doi:10.1371/journal.pgen.1000383. https://pubmed.ncbi.nlm.nih.gov/19214206/
5. Gong, Libao, Huang, Jiayi, Bai, Xue, Hang, Junjie, Guo, Jinfeng. 2024. Expression of HECTD2 predicts peritoneal metastasis of gastric cancer and reconstructs immune microenvironment. In Cancer cell international, 24, 380. doi:10.1186/s12935-024-03553-5. https://pubmed.ncbi.nlm.nih.gov/39548546/
智鼠故事 
